Proj. 4-The Genetic Variation of Innate Immune Genes w/Oral Manifestations of HIV
项目。
基本信息
- 批准号:8254425
- 负责人:
- 金额:$ 32.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:11pAIDS/HIV problemAcquired Immunodeficiency SyndromeAfricaAfrican AmericanAgonistAphthous StomatitisAreaAutoimmune DiseasesBacteriaCD4 Positive T LymphocytesCXCR4 geneCandidiasisCause of DeathCellsCessation of lifeChemotaxisChildCommunicable DiseasesComplexComplicationCytomegalovirusDEFB1 geneDefensinsDevelopmentDiseaseDisease ProgressionDisease susceptibilityEconomic FactorsEffectivenessEnvironmentEpidemicEpithelialEpithelial CellsEthnic OriginFamilyFamily memberFrequenciesGene ClusterGene DosageGene FamilyGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic VariationHIVHIV InfectionsHIV SeropositivityHairy LeukoplakiaHaplotypesHighly Active Antiretroviral TherapyHost DefenseHumanHuman PapillomavirusImmuneImmune System DiseasesImmune responseImmune systemImmunosuppressionIncidenceIndividualInfectionInflammation MediatorsInflammatoryKaposi SarcomaMaintenanceMediatingMicrobeMothersMucosal ImmunityNatural ImmunityOpportunistic InfectionsOralOral ManifestationsOral candidiasisOral cavityOral mucous membrane structureOutcomePathologyPatientsPeptidesPeriodontitisPlayPopulationPredispositionProcessPropertyRaceRiskRoleSignal TransductionSimplexvirusSingle Nucleotide PolymorphismStomatitisStructureSurfaceTLR1 geneTissuesToll-like receptorsUp-RegulationVariantVertical Disease TransmissionViralVirusantimicrobialbeta-Defensinsfungusmembermicrobialoral infectionoral lesionoral wartoutcome forecastreceptorresponsesocioeconomicstreatment response
项目摘要
Oral manifestations of HIV have been documented since the initial presentation of the HIV/AIDS epidemic of
the 80's. The most common oral complication was candidiasis, and was associated with a reduction in
CD4+T cells. Oral candidal infection was a hallmark indicator of immune dysfunction. The increased
incidence of opportunistic infections was related to immune suppression as evidenced by a reduction in
number and functional activity of CD4 + T cells. The frequency and type of oral complication has changed
since the initial description of the 80s. With the initiation of HAART therapies the constellation of oral
manifestations has changed. The incidence of HPV associated warts and severe aphthous ulcer stomatitis
has increased, whereas oral candidal infection and oral hairy leukoplakia has declined. In addition, not all
patients develop these pathologies. The variation in disease presentation and concomitant response to
therapy may be related to genetic predisposition of innate immune genes and variation in epithelial barrier
function. Innate immunity is increasingly being recognized as playing a critical role in host defense against
infectious diseases, including HIV. The defensin peptides have antimicrobial properties and are major
protective components of the epithelial mucosal barrier. Genetic variation of the defensin genes in the form
of SNPs and CNVs has been shown to be associated with disease susceptibility. Toll-like receptors (TLRs),
a family of evolutionary conserved receptors on host cells including human oral epithelial cells, recognize
specific microbial structures, leading to the up-regulation of inflammatory mediators and recruitment of
inflammatory cells. Multiple interactions of microbes and host tissues and secreted antimicrobial molecules
such as beta-defensins are involved in the maintenance of the homeostatic environment of the healthy
mouth, however, little is known about the role of TLRs in this process or the impact of HIV disease on these
processes. Polymorphisms in the TLR family and the common adaptor Tirap/Mal have been associated with
many human infectious and autoimmune diseases. We hypothesize that host variation in TLRs and their
signaling components contribute to the variability in oral infections seen in HIV disease by altering
host/microbe interactions at the mucosal surface. We will decipher the relationship of genetic variations in
both the defensin gene cluster and toll-like receptors TLR1 and 2 with oral manifestations of HIV/AIDS. We
will define and correlate specific complex haplotypes with the frequency and occurrence of oral lesions in the
HIV population. We hypothesize that susceptibility, prognosis, and outcome of HIV are associated with
genetic variations in the defensin gene cluster. This same variation also may be associated with the
development of oral complications following HIV infection
自从首次出现艾滋病毒/艾滋病流行以来,艾滋病毒的口腔表现就已被记录在案。
80年代。最常见的口腔并发症是念珠菌病,与口腔细菌感染减少有关。
CD4+T细胞。口腔念珠菌感染是免疫功能障碍的标志性指标。增加的
机会性感染的发生率与免疫抑制有关,这一点可以通过减少
CD4 + T 细胞的数量和功能活性。口腔并发症的频率和类型发生了变化
自 80 年代最初描述以来。随着 HAART 疗法的启动,一系列口服药物
表现形式发生了变化。 HPV相关疣和严重口疮性溃疡性口腔炎的发生率
增加,而口腔念珠菌感染和口腔毛状白斑减少。此外,并非所有
患者出现这些病症。疾病表现和伴随反应的变化
治疗可能与先天免疫基因的遗传倾向和上皮屏障的变化有关
功能。人们越来越认识到先天免疫在宿主防御病毒方面发挥着关键作用。
传染病,包括艾滋病毒。防御素肽具有抗菌特性,是主要的防御素肽。
上皮粘膜屏障的保护成分。防御素基因的遗传变异形式
SNP 和 CNV 的数量已被证明与疾病易感性相关。 Toll 样受体 (TLR)、
包括人类口腔上皮细胞在内的宿主细胞上进化保守的受体家族,识别
特定的微生物结构,导致炎症介质的上调和招募
炎症细胞。微生物和宿主组织以及分泌的抗菌分子的多重相互作用
例如β-防御素参与维持健康的体内平衡环境
然而,人们对 TLR 在此过程中的作用或 HIV 疾病对这些过程的影响知之甚少。
流程。 TLR 家族和通用接头 Tirap/Mal 中的多态性与
许多人类传染病和自身免疫性疾病。我们假设 TLR 的宿主变异及其
信号成分通过改变艾滋病毒疾病中口腔感染的变异性
粘膜表面的宿主/微生物相互作用。我们将破译遗传变异的关系
防御素基因簇和 Toll 样受体 TLR1 和 2 均与 HIV/AIDS 的口腔表现有关。我们
将定义特定的复杂单倍型并将其与口腔病变的频率和发生率相关联
艾滋病毒人群。我们假设 HIV 的易感性、预后和结果与
防御素基因簇的遗传变异。同样的变化也可能与
HIV 感染后口腔并发症的发展
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD J JUREVIC其他文献
RICHARD J JUREVIC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD J JUREVIC', 18)}}的其他基金
Proj. 4-The Genetic Variation of Innate Immune Genes w/Oral Manifestations of HIV
项目。
- 批准号:
8070380 - 财政年份:
- 资助金额:
$ 32.12万 - 项目类别:
Proj. 4-The Genetic Variation of Innate Immune Genes w/Oral Manifestations of HIV
项目。
- 批准号:
7685068 - 财政年份:
- 资助金额:
$ 32.12万 - 项目类别:
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 32.12万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 32.12万 - 项目类别:
Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease
HIV 和帕金森病导致的衰老过程中认知和运动功能变化的神经功能机制
- 批准号:
10619383 - 财政年份:2023
- 资助金额:
$ 32.12万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 32.12万 - 项目类别: